Abingdon Health (LON:ABDX) Stock Price Up 2.5% – Still a Buy?

Shares of Abingdon Health Plc (LON:ABDX) shot up 2.5% during trading on Thursday . The stock traded as high as GBX 6.50 and last traded at GBX 6.15. 511,024 shares changed hands during trading, an increase of 217% from the average session volume of 161,005 shares. The stock had previously closed at GBX 6.

Abingdon Health Stock Performance

The company has a debt-to-equity ratio of 46.64, a quick ratio of 1.96 and a current ratio of 1.95. The company has a market cap of £15.44 million, a PE ratio of -6.61 and a beta of 0.13. The business’s 50-day moving average is GBX 6.41 and its 200 day moving average is GBX 6.33.

Abingdon Health (LON:ABDX) last posted its quarterly earnings results on Tuesday, November 11th. The company reported GBX (0.71) earnings per share (EPS) for the quarter. Abingdon Health had a negative net margin of 20.72% and a negative return on equity of 62.56%.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.